by Raven Reddy | Jun 13, 2025 | Press Releases
Introduction The process of drug development is fraught with uncertainty, requiring companies to make high-stakes decisions across a landscape defined by scientific complexity, long timelines, regulatory unpredictability, and commercial risk. Despite advances in...
by Raven Reddy | May 29, 2025 | Press Releases
New company delivers AI-powered portfolio modeling platform to support capital allocation, risk management and innovation in drug development Cambridge, MA–May 29, 2025–QLS Technologies LLC launched today as a spinout from QLS Advisors LLC, with a mission...
Recent Comments